Kevin Wahle

Kevin Wahle is a Senior Equity Analyst at Invenomic Capital Management LP, a Boston-based hedge fund manager. In his current role, he is responsible for covering equities across multiple sectors, contributing to idea generation and fundamental analysis for the firm's long/short strategies. His coverage includes a broad spectrum of industries, leveraging cross-sector insights to identify opportunities and risks in publicly traded U.S. companies.

Prior to joining Invenomic Capital Management, Kevin held analyst roles at Noble Capital Markets, focusing on research for small-cap companies and providing investment insights across healthcare, business services, defense technology, energy, and media & entertainment. His internships and previous roles have given him experience in both fundamental and technical equity analysis, as well as commodity risk modeling and sell-side equity research.

Kevin Wahle graduated from Creighton University in 2021 with a Bachelor of Science in Business Administration (BSBA) in Economics. At Invenomic, he has been recognized for his analytical rigor and breadth in sector coverage, supporting portfolio managers with actionable recommendations. His expertise spans equity research, sector trend analysis, and portfolio risk assessment within both hedge fund and broker/dealer environments.